• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿病与线粒体功能障碍的全面观察

A comprehensive perspective of Huntington's disease and mitochondrial dysfunction.

机构信息

National Clinical Research Center for Geriatrics Disorders, Department of Geriatrics, Xiangya Hospital, Central South University, Changsha, China; Xiangya School of Medicine, Central South University, Changsha, China.

Department of Physical Education and Research, Central South University, 932 Lushan South Rd., Changsha, China.

出版信息

Mitochondrion. 2023 May;70:8-19. doi: 10.1016/j.mito.2023.03.001. Epub 2023 Mar 10.

DOI:10.1016/j.mito.2023.03.001
PMID:36906250
Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative disease. It is caused by the expansion of the CAG trinucleotide repeat sequence in the HTT gene. HD mainly manifests as involuntary dance-like movements and severe mental disorders. As it progresses, patients lose the ability to speak, think, and even swallow. Although the pathogenesis is unclear, studies have found that mitochondrial dysfunctions occupy an important position in the pathogenesis of HD. Based on the latest research advances, this review sorts out and discusses the role of mitochondrial dysfunction on HD in terms of bioenergetics, abnormal autophagy, and abnormal mitochondrial membranes. This review provides researchers with a more complete perspective on the mechanisms underlying the relationship between mitochondrial dysregulation and HD.

摘要

亨廷顿病(HD)是一种常染色体显性神经退行性疾病。它是由 HTT 基因中 CAG 三核苷酸重复序列的扩展引起的。HD 主要表现为不自主的舞蹈样运动和严重的精神障碍。随着病情的发展,患者逐渐丧失说话、思考甚至吞咽的能力。尽管发病机制尚不清楚,但研究发现线粒体功能障碍在 HD 的发病机制中占有重要地位。基于最新的研究进展,本文从生物能量学、异常自噬和异常线粒体膜等方面对线粒体功能障碍在 HD 中的作用进行了梳理和讨论。本文为研究人员提供了一个更完整的视角,了解线粒体失调与 HD 之间的关系的机制。

相似文献

1
A comprehensive perspective of Huntington's disease and mitochondrial dysfunction.亨廷顿病与线粒体功能障碍的全面观察
Mitochondrion. 2023 May;70:8-19. doi: 10.1016/j.mito.2023.03.001. Epub 2023 Mar 10.
2
Mitochondrial structural and functional dynamics in Huntington's disease.亨廷顿舞蹈病中的线粒体结构与功能动力学
Brain Res Rev. 2009 Jun;61(1):33-48. doi: 10.1016/j.brainresrev.2009.04.001. Epub 2009 Apr 24.
3
Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.亨廷顿病中的线粒体异常与突触损伤:聚焦于有缺陷的线粒体自噬及线粒体靶向治疗
Mol Neurobiol. 2021 Dec;58(12):6350-6377. doi: 10.1007/s12035-021-02556-x. Epub 2021 Sep 14.
4
Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.Drp1/Fis1 介导的线粒体片段化导致亨廷顿病心脏模型中的溶酶体功能障碍。
J Mol Cell Cardiol. 2019 Feb;127:125-133. doi: 10.1016/j.yjmcc.2018.12.004. Epub 2018 Dec 11.
5
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.氧化 DNA 损伤在线粒体功能障碍和亨廷顿病发病机制中的作用。
Free Radic Biol Med. 2013 Sep;62:102-110. doi: 10.1016/j.freeradbiomed.2013.04.017. Epub 2013 Apr 18.
6
Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.突变型亨廷顿蛋白、异常的线粒体动力学、线粒体轴突运输缺陷以及亨廷顿病中的选择性突触退化。
Biochim Biophys Acta. 2012 Feb;1822(2):101-10. doi: 10.1016/j.bbadis.2011.10.016. Epub 2011 Nov 4.
7
Huntington's Disease: Relationship Between Phenotype and Genotype.亨廷顿舞蹈症:表型与基因型之间的关系
Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7.
8
Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease.亨廷顿病中线粒体 DNA 异质体的加速扩张。
Proc Natl Acad Sci U S A. 2021 Jul 27;118(30). doi: 10.1073/pnas.2014610118.
9
Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.亨廷顿病中线粒体动态异常、线粒体缺失和突变亨廷顿寡聚体:对选择性神经元损伤的影响。
Hum Mol Genet. 2011 Apr 1;20(7):1438-55. doi: 10.1093/hmg/ddr024. Epub 2011 Jan 21.
10
Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington's disease.亨廷顿病患者成纤维细胞中线粒体的组织和结构受损。
Ultrastruct Pathol. 2022 Sep 3;46(5):462-475. doi: 10.1080/01913123.2022.2100951. Epub 2022 Aug 10.

引用本文的文献

1
Mitophagy's impacts on cancer and neurodegenerative diseases: implications for future therapies.线粒体自噬对癌症和神经退行性疾病的影响:对未来治疗的启示
J Hematol Oncol. 2025 Aug 1;18(1):78. doi: 10.1186/s13045-025-01727-w.
2
An Updated and Comprehensive Review Exploring the Gut-Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies.一项探索神经退行性疾病和神经创伤中肠-脑轴的最新综合综述:对治疗策略的启示
Brain Sci. 2025 Jun 18;15(6):654. doi: 10.3390/brainsci15060654.
3
Phytochemicals as modulators of ferroptosis: a novel therapeutic avenue in cancer and neurodegeneration.
植物化学物质作为铁死亡的调节剂:癌症和神经退行性疾病治疗的新途径。
Mol Biol Rep. 2025 Jun 25;52(1):636. doi: 10.1007/s11033-025-10752-4.
4
Distinct molecular patterns in R6/2 HD mouse brain: Insights from spatiotemporal transcriptomics.R6/2转基因亨廷顿舞蹈症小鼠大脑中的独特分子模式:时空转录组学的见解
Neuron. 2025 Jun 6. doi: 10.1016/j.neuron.2025.05.014.
5
Inherent potential of mitochondria-targeted interventions for chronic neurodegenerative diseases.线粒体靶向干预对慢性神经退行性疾病的内在潜力。
Neural Regen Res. 2025 Apr 29. doi: 10.4103/NRR.NRR-D-24-01507.
6
Neurodegenerative diseases and neuroinflammation-induced apoptosis.神经退行性疾病与神经炎症诱导的细胞凋亡。
Open Life Sci. 2025 Feb 25;20(1):20221051. doi: 10.1515/biol-2022-1051. eCollection 2025.
7
F2,6BP restores mitochondrial genome integrity in Huntington's Disease.果糖-2,6-二磷酸可恢复亨廷顿舞蹈病中的线粒体基因组完整性。
bioRxiv. 2025 Jun 30:2024.11.04.621834. doi: 10.1101/2024.11.04.621834.
8
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease.针对亨廷顿病的衰老和细胞衰老的治疗方法。
CNS Neurosci Ther. 2024 Oct;30(10):e70053. doi: 10.1111/cns.70053.
9
Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets.缺氧与衰老:分子机制、疾病及治疗靶点。
MedComm (2020). 2024 Oct 15;5(11):e786. doi: 10.1002/mco2.786. eCollection 2024 Nov.
10
Neurodegenerative disorders, metabolic icebergs, and mitohormesis.神经退行性疾病、代谢冰山和线粒体激素。
Transl Neurodegener. 2024 Sep 6;13(1):46. doi: 10.1186/s40035-024-00435-8.